Zomedica Pharmaceuticals (ZOM)
US Market

Zomedica Pharmaceuticals (ZOM) Balance Sheet


Zomedica Pharmaceuticals Balance Sheet

Zomedica Pharmaceuticals's total assets for Q4 2023 were $253.20M, a decrease of -7.95% from the previous quarter. ZOM total liabilities were $13.18M for the fiscal quarter, a -6.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 253.20M$ 279.61M$ 280.40M$ 66.14M$ 4.18M
Total Liabilities
$ 13.18M$ 12.22M$ 9.51M$ 15.08M$ 2.09M
Total Equity Gross Minority
$ 240.02M$ 267.39M$ 270.89M$ 51.07M$ 2.10M
Total Capitalization
$ 241.83M$ 268.49M$ 270.89M$ 51.07M$ 2.10M
Preferred Stock Equity
----$ 11.96M
Capital Lease Obligations
---$ 1.34M$ 0.00
Currency in USD

Zomedica Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis